Results 251 to 260 of about 13,861,407 (312)
Some of the next articles are maybe not open access.
Nature Reviews Gastroenterology and Hepatology, 2011
The goal of hepatitis B treatment is to prevent cirrhosis, liver decompensation and hepatocellular carcinoma. In clinical practice, treatment response is determined by suppression of serum HBV DNA levels, hepatitis B e antigen seroconversion to hepatitis B e antibody, hepatitis B surface antigen loss, normalization of alanine aminotransferase levels ...
Anna S F Lok, Lok Anna S
exaly +3 more sources
The goal of hepatitis B treatment is to prevent cirrhosis, liver decompensation and hepatocellular carcinoma. In clinical practice, treatment response is determined by suppression of serum HBV DNA levels, hepatitis B e antigen seroconversion to hepatitis B e antibody, hepatitis B surface antigen loss, normalization of alanine aminotransferase levels ...
Anna S F Lok, Lok Anna S
exaly +3 more sources
Therapeutic strategies for hepatitis B virus infection: towards a cure
Nature Reviews Drug Discovery, 2019Fabien Zoulim +2 more
exaly +2 more sources
Drug and Alcohol Review, 1996
AbstractHepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide.
R G, Batey, S J, Bollipo
openaire +2 more sources
AbstractHepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide.
R G, Batey, S J, Bollipo
openaire +2 more sources
Current Treatment Options in Gastroenterology, 1999
The management of acute HBV infection is supportive. Specific treatment is not indicated for HBV carriers because they often have no evidence of liver injury, and, further, do not respond to currently available therapies. Interferon monotherapy is best indicated for patients with chronic replicating HBV infection and evidence of chronic hepatitis ...
, Weakley, , Rajender Reddy K
openaire +2 more sources
The management of acute HBV infection is supportive. Specific treatment is not indicated for HBV carriers because they often have no evidence of liver injury, and, further, do not respond to currently available therapies. Interferon monotherapy is best indicated for patients with chronic replicating HBV infection and evidence of chronic hepatitis ...
, Weakley, , Rajender Reddy K
openaire +2 more sources
Pediatric Clinics of North America, 1974
Viral hepatitis acquired after the neonatal period has been of two types, distinguished generally by their different incubation periods. Now better designated hepatitis A and hepatitis B, the history, clinical picture, differential diagnosis, and therapy of these disorders are discussed.
D H, Carver, D S, Seto
openaire +2 more sources
Viral hepatitis acquired after the neonatal period has been of two types, distinguished generally by their different incubation periods. Now better designated hepatitis A and hepatitis B, the history, clinical picture, differential diagnosis, and therapy of these disorders are discussed.
D H, Carver, D S, Seto
openaire +2 more sources
Infectious Disease Clinics of North America, 2000
The hepatitis B virus is a hepatotropic virus that can produce a variety of clinical syndromes in patients ranging in age from infants to elderly adults. Worldwide, it is among the leading causes of fulminant hepatic failure, cirrhosis, and hepatocellular carcinoma.
A S, Befeler, A M, Di Bisceglie
openaire +2 more sources
The hepatitis B virus is a hepatotropic virus that can produce a variety of clinical syndromes in patients ranging in age from infants to elderly adults. Worldwide, it is among the leading causes of fulminant hepatic failure, cirrhosis, and hepatocellular carcinoma.
A S, Befeler, A M, Di Bisceglie
openaire +2 more sources
Clinics in Liver Disease, 2004
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Andy S, Yu +2 more
openaire +3 more sources
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Andy S, Yu +2 more
openaire +3 more sources
Journal, 2016
Laboratory confirmation of infection as demonstrated by: Hepatitis B surface antigen (HBsAg) positive PLUS immunoglobulin M antibody to hepatitis B core antigen (anti-HBc IgM) positive in the context of a compatible clinical history or probable ...
L. Gallagher
semanticscholar +1 more source
Laboratory confirmation of infection as demonstrated by: Hepatitis B surface antigen (HBsAg) positive PLUS immunoglobulin M antibody to hepatitis B core antigen (anti-HBc IgM) positive in the context of a compatible clinical history or probable ...
L. Gallagher
semanticscholar +1 more source